These novel medications , Semaglutide , represent a groundbreaking advancement in addressing metabolic dysfunction and conceivably related disorders. These drugs are categorized as GLP-1 hormone stimulators, meaning they function to mimic the endogenous GLP-1 hormone , stimulating insulin production and reducing hunger . While Tirzepatide each one